Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A sterile **peritoneal dialysis solution** containing **dextrose, sodium lactate, sodium chloride, calcium chloride, and magnesium chloride**, developed and marketed by **Baxter Healthcare** for intraperitoneal use in patients with renal failure. In this combination, **dextrose acts as the osmotic agent** that drives ultrafiltration across the peritoneal membrane, enabling removal of excess water and uremic solutes, while **sodium lactate serves as the buffer precursor** and the electrolytes help maintain physiologic ionic composition during dialysis. This product family is marketed under brands including **DELFLEX** and **DIANEAL** formulations and is indicated for **chronic kidney failure** in peritoneal dialysis patients and, for certain DIANEAL products, **acute or chronic renal failure**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium lactate + calcium chloride + sodium chloride + magnesium chloride + dextrose.